Company / R&D Expense
Cooper Companies (The) R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$172.2M
FY2025
5-year range
$86.7M / $172.2M
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#44 of 110
Health Care
What the data says
At $172M, Cooper Companies (The)'s r&d expense ranks #44 of 110 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $65M in FY2016 to $172M in FY2025.
Based on SEC 10-K filings.
$172M in FY2025 with a 5-year CAGR of +15.2%.
Improved from $93M to $172M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +22.7%
- 5-Year CAGR
- +15.2%
- 10-Year CAGR
- -
Sector benchmark
#44 of 110 in Health CareTop 40% of 110This company $172.2M Sector average $298.2M
▼
-42.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.2%, indicating consistent growth.
- In FY2025, r&d expense increased 11.0% year-over-year.
- Ranks #44 out of 110 companies in the Health Care sector.
- Lowest r&d expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $172.2M | +11.0% |
| FY2024 | $155.1M | +67.3% |
| FY2023 | $92.7M | -0.6% |
| FY2022 | $93.3M | +7.6% |
| FY2021 | $86.7M | +2.2% |
| FY2020 | $84.8M | +22.5% |
| FY2019 | $69.2M | -18.4% |
| FY2018 | $84.8M | +21.8% |
| FY2017 | $69.6M | +6.4% |
| FY2016 | $65.4M | -6.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026